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We compared satisfactory for evaluation but limited by (limited by) and unsatisfactory gynecologic cytologic diagnoses for samples collected by conventional smearing with those generated with the AutoCyte Prep in a population with a historic squamous intraepithelial lesion (SIL) rate of less than 1%. Results from 18,819
Liquid-based, thin-layer gynecologic cytology when compared with conventional Papanicolaou (Pap) testing has been shown to increase the detection of low-grade squamous intraepithelial lesions (LSILs) [1] [2] [3] [4] and high-grade SILs (HSILs) 5 while reducing the number of cases that are considered unsatisfactory 3 and satisfactory for evaluation but limited by (designated as limited by herein). 1, 3 Problems reported with this technology include "rounding up" and disaggregation of HSIL cells, making them more difficult to recognize, and glandular cells that look more ominous or are fewer in number. 6 For AutoCyte Prep (TriPath Care Technologies, Burlington, NC) cytologic samples, a potential source for these problems may be the collection device. As opposed to conventional Pap testing in which use of an ectocervical spatula often is combined with use of an endocervical brush, 7 the AutoCyte Prep uses a combined ectocervical-endocervical (broom-type) sampling device. Theoretical concern with the broom-type device are failure to reach deeply enough into the endocervical canal and the bristles of the sampling device running parallel instead of perpendicular to the sampled orifice. In the present study, we found that use of the AutoCyte Prep, compared with conventional Pap smear preparations, significantly decreased the rate of unsatisfactory and limited by specimens and increased the detection of LSIL and cancer and the recovery of endocervical cells (ECs). In addition, while the majority of limited by specimens with the AutoCyte Prep was due to the absence of ECs, the use of an endocervical brush in combination with the AutoCyte Prep sampling device did not enhance recovery of ECs.
Materials and Methods
Analysis of Gynecologic Cytologic Diagnoses
We compared 18,819 AutoCyte Prep thin-layer cervical cytology specimens obtained within the Carle Clinic Association/Hospital system, Urbana, IL, from November 2000 to April 2001 with 53,835 conventional cervical smears obtained from November 1997 to April 1998, November 1998 to April 1999, and November 1999 to April 2000. The diagnostic terminology used was derived from the 1991 revision 8 of the Bethesda System. 9,10 Statistical comparison was performed using a 2 × 2 chi-square goodness-of-fit test with Yates correction for categoric variables less than 5 using Epi Info 6. 11 Assumptions made were that the incidence rates of LSIL, HSIL, and cervical cancer would remain constant in the 2 data sets. Statistical significance was considered achieved for P values less than .05.
Cytology/Cervical Biopsy Comparison
All AutoCyte Prep and conventional Pap tests performed at the Carle Clinic Association/Hospital system within the specified dates were reviewed. Gynecologic cytologic samples were paired with a corresponding cervical biopsy or excision specimen (cervical biopsy). Cases were excluded from analysis for the following reasons: (1) the cytologic and corresponding tissue diagnoses were separated in time by more than 6 months; (2) the cytologic and/or corresponding tissue diagnosis was reported as "quantity not sufficient for diagnosis" or "not diagnostic"; (3) the cytologic sampling and/or corresponding cervical biopsy were not performed and interpreted within the Carle Clinic Association/Hospital system; or (4) the cervical biopsy result contained a qualified diagnosis. A cervical biopsy diagnosis was deemed qualified if it contained the terms "suspicious for," "probable," "possible," "likely," and/or "questionable for." 12 When multiple cervical biopsies were performed, the cytologic sample closest in temporal relationship to the cervical biopsy was correlated. A positive correlation was identified if there was no more than a 1-step difference between the cytologic and cervical biopsy diagnoses. The concordant diagnostic pairs were as follows: cervical, atypical squamous cells of undetermined significance (ASCUS) and biopsy, LSIL; cervical, LSIL and biopsy, HSIL; cervical, HSIL and biopsy, cancer; cervical, HSIL and biopsy, LSIL; and cervical, cancer and biopsy, HSIL. All other combinations were considered discordant.
Dual Endocervical Sampling
After providing informed consent, 23 women ages 16 to 65 years receiving routine cervical examinations underwent sampling with the AutoCyte Prep sampling device according to the manufacturer's instructions. For all patients, immediate resampling with the Surgipath C-E brush (Surgipath, Richmond, IL) was performed, and the brush head was clipped off and placed in an AutoCyte Prep collection vial different from the vial used for the sample obtained with the AutoCyte Prep sampling device. Both specimens were processed routinely, and then the residual materials were combined and processed again. ECs were considered present if they appeared as a group of 6 or more cells.
Results
Statistical Comparison of AutoCyte Prep Cytologic Findings With Conventional Pap Smears
Comparison of liquid-based, thin-layer gynecologic cytology with conventional cytology usually has been performed in populations with an SIL prevalence greater than 2%. 4, 5, 13 To compare the AutoCyte Prep samples with conventional cytologic samples in a population with a historic SIL prevalence of less than 1%, 18,819 AutoCyte Prep samples and 53,835 conventional smears were examined and compared statistically using a chi-square test with Yates correction. ❚Table 1❚ shows that cytologic samples generated by the AutoCyte Prep were more likely to be negative and less likely to be unsatisfactory or limited by. The AutoCyte Prep generated more LSIL and squamous cell carcinoma or adenocarcinoma diagnoses. The HSIL rate was not different in the 2 populations. In terms of atypical diagnostic categories, ASCUS favor dysplasia and atypical glandular cells of undetermined significance (AGUS) were not different statistically between AutoCyte Prep cytologic samples and conventional smears. ASCUS favor reactive was higher in the AutoCyte Prep group. The ASCUS/SIL ratios for the AutoCyte Prep and conventional smears were 1.37 and 2.00, respectively, and the AGUS/SIL ratios were 0.14 and 0.26, respectively. The false-negative fraction 14 was higher with the AutoCyte Prep. Taken together, these data indicate that in a population with a low SIL prevalence, the AutoCyte Prep increases the detection of LSIL and cancer detection and reduces the number of Pap tests that are difficult to interpret owing to technical reasons.
Accuracy of AutoCyte Prep System Cytologic Diagnoses Compared With Conventional Pap Smear Diagnoses
False-negative rates for gynecologic cytology usually are reported in a combined manner with interpretation and screening errors pooled with sampling errors. To determine whether the AutoCyte Prep affected diagnostic errors exclusive of sampling, AutoCyte Prep cytologic diagnoses were compared with conventional Pap smear diagnoses as matched cytology-cervical biopsy pairs. ❚Table 2❚ shows that when 233 AutoCyte Prep cytologic and matched cervical biopsy diagnoses and 677 conventional Pap smear diagnoses and matched cervical biopsy diagnoses were examined, no false-positive Pap test results were identified. False-negative rates were 1.7% (n = 4) and 1.9% (n = 13) for the AutoCyte Prep and conventional smears, respectively (P < .934). Taken together, these data indicate that the AutoCyte Prep did not significantly affect the diagnostic accuracy of the Pap test when the tissue biopsy diagnosis was used as the "gold standard."
Categorization of Limited By Diagnoses for AutoCyte Prep and Conventional Pap Tests
As shown in Table 1 and (4) poor fixation (air drying). Taken together, these data indicate that the AutoCyte Prep, compared with the conventional Pap smear, improves the Pap test result in areas related to both sampling (improved EC recovery and cellularity) and smear preparation (obscuring elements and fixation). Table 3 shows that from a percentage standpoint, the smallest improvement in lowering Pap test limited by diagnoses was in the "No ECs" category. To try to increase EC recovery in AutoCyte Prep samples, single-brush sampling was compared with dual-brush sampling in 23 women undergoing routine Pap testing. ❚Table 4❚ shows that in samples obtained with the AutoCyte Prep sampling device (broom-type device), no samples had fewer than 1 group of 6 or more ECs. Immediate resampling with the Surgipath C-E brush showed 2 patients (cases 8 and 11) with no qualifying EC groups (6 or more cells). Interestingly, when the residuals from the broom device were combined with the samples from the Surgipath device, 1 sample (case 1) had no qualifying EC groups and 8 AutoCyte Prep samples (cases 2, 7-12, and 16) had fewer than half the number of qualifying groups as in the corresponding sample with the greatest number of EC groups. Taken together, these data indicate that dual sampling used to recover increased numbers of ECs offers no improvement over single AutoCyte device sampling.
Comparison of Single-and Dual-Brush Sampling on EC Recovery in the AutoCyte Prep System
Discussion
These data establish that the AutoCyte Prep, compared with conventional Pap smear preparations, significantly decreased the rate of unsatisfactory and limited by specimens and increased the detection of LSIL and cancer. Comparison of AutoCyte Prep and conventional Pap test statistics in Table 1 shows that the AutoCyte Prep reduced unsatisfactory and limited by Pap diagnoses and the ASCUS/SIL ratio by 97%, 67%, and 32%, respectively, and increased the detection of cancer and LSIL, the frequency of ASCUS favor reactive, and the false-negative fraction by 300%, 86%, 24%, and 94%, respectively. The rates for the detection of HSIL, ASCUS favor dysplasia, and AGUS were unchanged. Tissue correlation (Table 2) (Table 3) showed that in all categories examined, the AutoCyte Prep reduced limited by cases, including those limited by no EC component. In addition, the majority of limited by cases with the AutoCyte Prep were due to no ECs compared with obscuring inflammation for conventional smears. It is important to note that the use of an EC brush in combination with the AutoCyte Prep broom-type sampling device (Table 4) did not enhance EC recovery.
Our findings (Table 1) demonstrate that the AutoCyte Prep significantly increased detection of LSIL and cancer but not of HSIL. The LSIL results are consistent with previously published work. 2, 4, 13 The increased detection of cancer has not been reported previously. The HSIL rate has been shown not to increase with the AutoCyte Prep, even though the LSIL rate increases. 2 It also has been demonstrated that the AutoCyte Prep increases both LSIL and HSIL. 13 It is important to note that increased cancer detection was coupled with no significant increase in false-positive Pap diagnoses when cervical biopsy was used as the gold standard (Table 2) . These results indicate that the AutoCyte Prep is a more accurate screening test for the diagnosis of precancerous and cancerous lesions of the cervix. This conclusion is further supported by examination of the ASCUS/SIL and AGUS/SIL ratios for AutoCyte Prep samples compared with conventional smears since both of these ratios were reduced. Interestingly, the number of diagnoses reported as ASCUS favor reactive were increased with the AutoCyte Prep, but this small increase was offset by a larger increase in the SIL rate. In addition, no significant increase in cases reported as AGUS were found when examining AutoCyte Prep diagnoses. This indicates that overinterpretation of benign glandular elements is not increased with the AutoCyte System compared with conventional Pap smears as has been speculated. 6 Finally, there also were significant reductions in slides obscured by inflammation, blood, bacteria, and cytolysis in AutoCyte Prep samples compared with conventional smears. This is likely due to the density reagent used in the AutoCyte Prep System that allows for slower sedimentation of smaller cells (neutrophils and RBCs) and cell debris (cytoplasmic fragments and naked nuclei), leading to a reduction of this material on the slide. With the overall improvement statistically in the performance of the AutoCyte Prep, it was unexpected to find a near doubling of the false-negative fraction. Since the falsenegative fraction relies on the assumption that in a given population of rescreened Pap smears the entire population of Pap smears will have the same miss rate, the rescreened percentage is a critical variable. In the present study, the rescreened percentage achieved for both the AutoCyte Prep and conventional smears was 30%. Therefore, parity was achieved with regard to this variable. Essex-Sorlie et al 12 have shown that diagnostic uncertainty is inversely proportional to disease prevalence by using the following formula: QDN = nQDs × (PFNO/DPEP) where QDN is the number of qualified diagnoses classified as negative; nQDs is the total number of qualified diagnoses; PFNO is the proportion of false-negative outcomes; and DPEP is the disease prevalence expressed as a proportion. This formula predicts that as a disease becomes more prevalent in a population, the likelihood increases that a person with only some of the criteria for that disease actually has the disease. Therefore, for the false-negative fraction, this same concept may be applicable. As Table 1 shows, the prevalence for LSIL + HSIL + cancer increased in the AutoCyte Prep to 1.6% from that for the conventional Pap test of 0.9%. This near doubling of prevalence is supported in that no Pap test false-positive results were identified when correlated with cervical biopsy diagnoses ( Table  2) . If the assumption is made that screening errors are an inherent fixed value for a given set of screeners (supported again in Table 2 by the demonstration that the interpretation and screening error rates for the AutoCyte Prep and conventional smears were not significantly different), then the false-negative fraction should increase as the disease prevalence increases. Our findings suggest that disease prevalence has a critical impact on the false-negative fraction and that benchmarking laboratory performance to the falsenegative fraction without taking into account disease prevalence may need reevaluation.
It has been reported that the AutoCyte Prep undersamples the endocervix, resulting in increased limited by diagnoses owing to the lack of an EC component. 5 This same rationale also has been suggested as the cause of increased detection of LSIL without concomitant increases in the detection of HSIL. Our data show that with the AutoCyte Prep, the vast majority (87.6%) of the AutoCyte limited by diagnoses were due to the lack of an EC component, but that of the total number of cases examined during the study period, only about 6% of the AutoCyte cases were limited by a lack of ECs compared with approximately 9% of the conventional samples. These results indicate that the AutoCyte broom-type device is better at sampling the endocervix than the combined spatula and brush devices formerly used at our institution. To attempt to further improve on the broom device, we double sampled 23 women with both broom and brush devices, with the broom preceding the brush. Table 4 demonstrates that the broom device was 100% successful at adequately sampling the endocervix, while the brush was not. This was not surprising given the low prevalence of insufficient ECs (6.2%) and given the sampling order, with the first device usually having an advantage in tandem studies. What was interesting, however, was that when the residuals from each sample were combined and processed to generate a third slide, 9 of 23 cases had fewer ECs (by at least 50%) than the original sample with the most ECs.
